ArticleRevista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia2022

Nirmatrelvir/ritonavir as a potential treatment for prolonged SARS-CoV-2 infection in immunocompromised patients.

I Pérez Catalán et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.